Clinical significance of cellular immunity function and inflammatory factors assays in alveolar lavage fluid for severe COVID‐19 pneumonia

Liang Liao,Guo‐hui Yang
DOI: https://doi.org/10.1002/jmv.26827
IF: 20.693
2021-02-09
Journal of Medical Virology
Abstract:<p>In this study, we aimed to investigate the changes of lymphocyte subsets (CD3+, CD4+, CD8+) and inflammatory factors (IL‐6, HS‐CRP and procalcitonin (PCT)) of alveolar lavage fluid in patients with severe COVID‐19 pneumonia and their clinical impact on the assessment of disease severity and prognosis. 24 patients with severe COVID‐19 pneumonia were admitted to the ICU of the Ezhou Central Hospital from February 1 to March 22, 2020. According to the 28‐day prognosis, they were assigned to a death group and a survival group. On the 3rd day of ICU admission, peripheral blood and alveolar lavage fluid were collected for examination of lymphocyte subsets and inflammatory factors by flow cytometry and immunoturbidimetry, respectively. The CD3+, CD4+, and CD8+ cell counts in alveolar lavage fluid and serum were significantly higher in the survival group than those of the death group (P&lt;0.05). The levels of IL‐6, HS‐CRP and PCT in alveolar lavage fluid and serum of the death group were statistically higher than those of the survival group (P&lt;0.05); The CD3+, CD4+ cell count and IL‐6 level were negatively correlated with SOFA and APACHE II scores, respectively (P&lt;0.05). The CD4+ cell and SOFA score have a regression relationship with the prognosis of COVID‐19 severe patients. The CD3+, CD4+, CD8+ cells and IL‐6 levels are valuable in determining the prognosis of the severe COVID‐19 pneumonia and are strongly correlated with the severity of the disease; the CD4+ cell is an independent risk factor affecting the prognosis of COVID‐19 pneumonia.</p><p>This article is protected by copyright. All rights reserved.</p>
virology
What problem does this paper attempt to address?
The problem this paper attempts to address is: by detecting changes in cellular immune function and inflammatory factors in the bronchoalveolar lavage fluid of critically ill COVID-19 patients, to explore the clinical significance of these changes in assessing disease severity and prognosis. Specifically, the study aims to understand the impact of cellular immune function and inflammatory response on disease progression and prognosis, providing a theoretical basis for the immune status and systemic inflammatory response of critically ill COVID-19 patients. ### Main Research Content: 1. **Study Subjects**: 24 critically ill COVID-19 pneumonia patients, divided into survival and death groups. 2. **Detection Indicators**: Peripheral blood and bronchoalveolar lavage fluid were collected on the 3rd day of admission to detect lymphocyte subsets (CD3+, CD4+, CD8+) and inflammatory factors (IL-6, high-sensitivity C-reactive protein [HS-CRP], procalcitonin [PCT]). 3. **Statistical Analysis**: Statistical analysis was performed using SPSS 23.0 to compare the differences between the two groups, and correlation analysis and binary logistic regression analysis were conducted. ### Main Findings: 1. **Comparison between Survival and Death Groups**: - The CD3+, CD4+, and CD8+ cell counts in the survival group were significantly higher than those in the death group. - The levels of IL-6, HS-CRP, and PCT in the survival group were significantly lower than those in the death group. 2. **Correlation Analysis**: - CD3+ and CD4+ cell counts and IL-6 levels were negatively correlated with SOFA scores and APACHE II scores. 3. **Binary Logistic Regression Analysis**: - CD4+ cell count and SOFA score were independent risk factors affecting the prognosis of critically ill COVID-19 pneumonia patients. ### Conclusion: - CD3+, CD4+, CD8+ cell counts and IL-6 levels are closely related to the severity and prognosis of the disease. - CD4+ cell count and SOFA score can be used as effective indicators for assessing the prognosis of critically ill COVID-19 pneumonia patients. This study provides an important theoretical basis for understanding the immune function and inflammatory response of critically ill COVID-19 pneumonia patients, helping clinicians better assess the patient's condition and prognosis.